Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Repligen Cp (NQ: RGEN )

209.93 USD -2.93 (-1.38%)
Streaming Delayed Price Updated: 10:36 AM EDT, Apr 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Repligen Cp

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
10 Biggest Price Target Changes For Monday
Canaccord Genuity raised the price target on Tesla, Inc. (NASDAQ: TSLA) from $419 to $1071. Tesla shares rose 1.5% to $687.13 in ... 
Tags CENTA Price Target Changes Analyst Ratings
From Benzinga
7 Big Names That Could Be the Next Tesla
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These names are major disruptors in their respective industries. Could one of them be the next Tesla? I certainly think so. The post 7 Big... 
Tags TRUP NASDAQ:TSLA,NASDAQ:APPS,NASDAQ:RGEN,NASDAQ:ETSY,NASDAQ:TRUP,NYSE:NIO,NASDAQ:OKTA,NASDAQ:LOVE LOVE
From InvestorPlace
3 Overlooked Healthcare Stocks to Buy Right Now
Financial media can often divert your attention away from the best investments. 
Tags RGEN Market News DXCM
From Motley Fool
3 Disruptive Stocks to Buy and Hold for the Next Decade
These companies are set to keep riding upward thanks to long-term secular trends. 
Tags TMO RGEN Market News
From Motley Fool
Dow Jones, Nasdaq Erase Losses As Stocks Rise Into The Close
The Dow Jones Industrial Average rose over 100 points in today's stock market, while the major indexes all traded higher off their lows of the day. 
From Investor's Business Daily
Stocks With Rising Relative Strength: Repligen
A Relative Strength Rating upgrade for Repligen shows improving technical performance. Will it continue? 
From Investor's Business Daily
Stocks Showing Improved Relative Strength: Repligen
A Relative Strength Rating upgrade for Repligen shows improving technical performance. Will it continue? 
From Investor's Business Daily
Repligen Larger Than S&P 500 Component Allegion
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Repligen Corp. (RGEN) was identified as having a larger market cap than the smaller end of the S&P 500, for... 
Tags Stocks
From Market News Video
Peek Under The Hood: IVOG Has 11% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotech Stocks Can Provide Growth and Value in a Volatile Market
Healthcare stocks lagged in February with the rebalancing. 
Tags Healthcare ETFs Stocks / Equities
From Blogs - TalkMarkets
Better Buy: iShares Russell 2000 Growth ETF vs Schwab U.S. Small-Cap ETF
Small caps have outperformed large caps over the past year, so investors may want more exposure to them. 
Tags IWO PLUG DECK
From Motley Fool
10 Biggest Price Target Changes For Thursday
Needham raised NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 2.9% to $563.31 in pre-market ... 
Tags VCEL PING Price Target Changes
From Benzinga
Repligen Corp (RGEN) Q4 2020 Earnings Call Transcript
RGEN earnings call for the period ending March 31, 2021. 
Tags Market News RGEN
From Motley Fool
Repligen: Q4 Earnings Insights
Shares of Repligen (NASDAQ:RGEN) remained unaffected after the company reported Q4 results. Quarterly Results Earnings ... 
Tags RGEN Market News BZI/Recaps
From Benzinga
Repligen Earnings Easily Beat, Guidance Strong
Repligen easily beat earnings and revenue views and guided high for the current fiscal year. RGEN stock jumped Wednesday. 
From Investor's Business Daily
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SRPT HALO NRBO
From Benzinga
Earnings Scheduled For February 24, 2021
Companies Reporting Before The Bell • Pinnacle West Capital (NYSE:PNW) is expected to report quarterly earnings at ... 
Tags WTRG UIHC TNDM
From Benzinga
Stocks Showing Rising Market Leadership: Repligen Earns 81 RS Rating
Repligen sees its Relative Strength Rating move into the 80-plus level. 
From Investor's Business Daily
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags PLSE PEN CMRX
From Benzinga
5 IBD 50 Biotech Stocks In Motion, Three Near Buy Point
Ligand is the runaway train among IBD 50 biotech stocks, but three others are in buy ranges or below buy points ahead of their earnings reports. 
From Investor's Business Daily
Repligen Stock Doubled In 2020 — Why Covid Demand Is Fueling It
When it comes to coronavirus vaccines, think of Repligen as the man behind the curtain and RGEN stock as a tools powerhouse. Shares broke out of a cup base in January and hover in a buy zone. 
From Investor's Business Daily
Noteworthy Tuesday Option Activity: SIX, RGEN, CEVA
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Six Flags Entertainment Corp (SIX), where a total volume of 6,001 contracts has... 
Tags Stocks
From Market News Video
Dow Jones, S&P 500 Up Slightly After Giving Up Gains; Microsoft In Buy Zones Ahead Of Earnings
The Dow Jones Industrial Average traded around breakeven in today's stock market, while the S&P 500 edged up from earlier highs of the day. 
From Investor's Business Daily
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech DVAX SYNH
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News INFI EVLO
From Benzinga
Repligen In Buy Zone
Repligen is in a buy zone following two weeks of strong gains. RS line picking up. 
From Investor's Business Daily
Stock Market Analysis: Nasdaq Pullback Healthy; SolarEdge, Yatsen IPO Dive, Repligen In Buy Zone
Stock market analysis: Nasdaq pullback healthy; SolarEdge, Yatsen IPO dive, Repligen in buy zone. 
From Investor's Business Daily
Shopify: One Of Two Sector Leader Stocks Still In Potential Buy Range
Shopify stock is one of six Sector Leaders still in potential buy range as key market indexes slip from record highs. Who else finished in buy zone? 
From Investor's Business Daily
IBD 50: A Strong Week For Growth Stocks, Small Caps, With A Few Warning Signs
Repligen and Generac were two of the IBD 50 growth stocks that ended the week in buy ranges. But a number of other breakouts flashed some warnings signs. 
From Investor's Business Daily
Why This IBD Stock Of The Day Is On A Run As Covid Vaccine Demand Surges
Repligen is the IBD Stock Of The Day. Shares of RGEN stock are lingering in a chase zone after busting out of a cup base on Thursday. The company is a leader in bioprocessing. 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.